摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Methyl-dihydro-(2H)-pyran-2-one | 63127-54-8

中文名称
——
中文别名
——
英文名称
Methyl-dihydro-(2H)-pyran-2-one
英文别名
methyl-dihydro-pyranone;3-methyl-3,4-dihydropyran-2-one
Methyl-dihydro-(2H)-pyran-2-one化学式
CAS
63127-54-8
化学式
C6H8O2
mdl
——
分子量
112.128
InChiKey
VKXQOHIRQZRZAM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.1
  • 重原子数:
    8
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    26.3
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

点击查看最新优质反应信息

文献信息

  • Mechanistic and synthetic aspects of the acid-catalysed hydrolysis of 2,2-dimethoxy-3,4-dihydropyrans into 3,4-dihydro-α-pyrones and δ-keto esters
    作者:J.W. Scheeren、C.G. Bakker、R. Peperzak、R.J.F. Nivard
    DOI:10.1016/s0040-4039(00)95431-5
    日期:1987.1
    Acid-catalysed hydrolysis of 2,2-dimethoxy-3,4-dihydropyrans () yields mixtures of δ-keto esters () and 3,4-dihydro-α-pyrones (). The amount of increases with increasing alkyl substitution in the 3-, 5- and 6-position of and when the hydrolysis is carried out in a two-phases system of water/dichloromethane. It is shown that is formed directly from whereas is formed directly from and by methanolysis
    酸催化的2,2-二甲氧基-3,4-二氢吡喃()水解生成δ-酮酸酯()和3,4-二氢-α-吡喃酮()的混合物。当在水/二氯甲烷的两相系统中进行水解时,随着在3位,5位和6位烷基的取代增加而增加的量。结果表明,甲醇直接由形成,而甲醇则由甲醇直接形成。讨论了这些水解反应的机理和合成方面。
  • PLOUIN D.; BEAUME-COEUR C.; GLENAT R., C. R. ACAD. SCI., 1977, C284, NO 8, 343-346
    作者:PLOUIN D.、 BEAUME-COEUR C.、 GLENAT R.
    DOI:——
    日期:——
  • INNOCENTI, ALESSANDRO DEGL;RICCI, ALFREDO;MORDINI, ALESSANDRO;REGINATO, G+, GAZZ. CHIM. ITAL, 117,(1987) N 11, 645-648
    作者:INNOCENTI, ALESSANDRO DEGL、RICCI, ALFREDO、MORDINI, ALESSANDRO、REGINATO, G+
    DOI:——
    日期:——
  • SCHEEREN J. W.; BAKKER C. G.; PEPERZAK R.; NIVARD R. J. F., TETRAHEDRON LETT., 28,(1987) N 16, 1821-1824
    作者:SCHEEREN J. W.、 BAKKER C. G.、 PEPERZAK R.、 NIVARD R. J. F.
    DOI:——
    日期:——
  • COMPOSITIONS AND METHODS FOR TREATING CANCER AND DISEASES AND CONDITIONS RESPONSIVE TO CELL GROWTH INHIBITION
    申请人:THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    公开号:US20160015709A1
    公开(公告)日:2016-01-21
    In alternative embodiments, the invention provides compositions and methods for overcoming or diminishing or preventing Growth Factor Inhibitor resistance in a cell, or, a method for increasing the growth-inhibiting effectiveness of a Growth Factor inhibitor on a cell, or, a method for re-sensitizing a cell to a Growth Factor Inhibitor, comprising for example, administration of a combination of a TBK1 inhibitor and an RTK inhibitor. In alternative embodiments, the cell is a tumor cell, a cancer cell or a dysfunctional cell. In alternative embodiments, the invention provides compositions and methods for determining: whether an individual or a patient would benefit from or respond to administration of a Growth Factor Inhibitor, or, which individuals or patients would benefit from a combinatorial approach comprising administration of a combination of: at least one growth factor and at least one compound, composition or formulation used to practice a method of the invention, such as an NFKB inhibitor, such as a lenalidomide or a REVLIMID™, or IKK inhibitor; or an inhibitor of Galectin-3.
查看更多